Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts

Blood, Vol. 105, Issue 6, 2480-2486, March 15, 2005
This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef

Regulation of human auto- and alloreactive T cells by indoleamine 2,3-dioxygenase (IDO)–producing dendritic cells: too much ado about IDO?
Blood Terness et al. 105: 2480

Supplemental materials for: Terness et al, Vol 105, Issue 6, 2480-2486

Files in this Data Supplement:

  • Figure S1. T-cell regulatory property of dendritic cells pretreated with TNF-α and IFN-γ. (PDF, 40 KB) - Mature Dendritic Cells (mDCs) of 8 healthy donors, in which IDO synthesis was stimulated by an enhancer (1000U/ml TNF-) in addition to IFN- (1000U/ml), were co-cultured at decreasing ratios with autologous anti-CD3-stimulated T cells for 3 days. The control consisted of mDCs without IDO-inducer. Proliferation was assessed by adding [3H]thymidine. Single values represent the percentage of maximum stimulation (=100%). The difference between the T-cell stimulatory capacity of native DCs and IDO-DCs was statistically not significant.
  • Figure S2. Complete suppression of T-cell proliferation by dendritic cells pretreated with protein synthesis inhibitor. (PDF, 24 KB) - Mature Dendritic Cells of 3 healthy donors were loaded with MBP, treated for 30 min. with a selective protein synthesis inhibitor (=PI; 100µg/ml) and extensively washed. Vital staining with subsequent FACS analysis showed unimpaired cell viability. PI-treated as well as untreated DCs were coincubated at a ratio of 1:10 with H. saimiri-transformed MBP-specific T cells (clone ES-BP8T). DCs and T cells shared at least one HLA-DR antigen. Controls consisted of MBP-DCs or T cells only. Cell proliferation was measured after 4 days by [3H]thymidine incorporation. Data represent mean $#177; SD and are expressed as a percentage of the positive control values (= 100%). PI-treated DCs completely suppress the T-cell response, showing that suppression below basic proliferation of transformed T cells is possible.




This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020